- Apheresis Devices
- Automated Technologies
- Cell Therapy Technologies (Cell Washing and Processing)
- Blood Bags
- Leukocyte Depletion Filters
- Buffy Coat Pooling System
Transfusion Medicine Market size was valued at USD 4.4 billion in 2023 and is expected to reach a value of USD 7.1 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2030. The global market provides a detailed overview of the market, segmented by product type, application, and end-user. By Product Type, the Transfusion Medicine market has been segmented into Instruments and Accessories. The Accessories segment is likely to be the largest and fastest-growing segment in terms of product type. Based on Application, the Transfusion Medicine is segmented into Apheresis, Autotransfusion, and Blood Processing. The Blood Processing segment is predicted to register the fastest growth rate from 2023-to 2029. Based on the End User, the Transfusion Medicine market is segmented into Hospitals, Laboratories, and Others. According to precision business insights, laboratories are anticipated to hold the largest share market in the forecast period.
Transfusion Medicine Market Key Developments:
- In September 2021, Hemanext, a blood storage tech developer, raised USD 15 million funds via new series A funding round and USD 100 million from private equity. It aims to expand the Hemanext One System processes across the globe.
Transfusion Medicine Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7%
Largest Market
North America
Fastest Growing Market
North America
Transfusion Medicine Market Dynamics
The rising prevalence of chronic and infectious diseases like severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, thrombocytopenia, and the introduction of technologically advanced products are among the factors driving transfusion medicine demand.
North-America Got Significant Share
Transfusion Medicine Market Regional Analysis
The North American market is expected to witness the highest market share during the forecast period by region.
Latin America
Europe
Asia Pacific
Middle East
North America
Transfusion Medicine Market Segmentation
By Product Type
By End User
- Hospital Chains
- Standalone Hospitals
- Blood Banks
By End User Type
- Public
- Private
Frequently Asked Questions
The Transfusion Medicine Market is projected to expand at a CAGR of 7.0% during the forecast period.
The major players in the global Transfusion Medicine market are Medtronic, Fresenius Kabi, Terumo, MEDICA S.P.A., Haier Biomedical, Haemonetics, and LivaNova plc., Lmb Technologie GmbH, Delcon, Sarstedt AG &Co. KG.
North America is the fastest-growing region for Transfusion Medicine Market
Key Features of the Reports
- The transfusion medicine market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1. Executive Summary |
| 2. Global Transfusion Medicine Market Introduction |
| 2.1. Global Transfusion Medicine Market - Taxonomy |
| 2.2. Global Transfusion Medicine Market - Definitions |
| 2.2.1. Product Type |
| 2.2.2. End User |
| 2.2.3. End User Type |
| 2.2.4. Region |
| 3. Global Transfusion Medicine Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Key Developments |
| 4. Global Transfusion Medicine Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 4.1. Apheresis Devices |
| 4.1.1. Plasmapheresis Devices |
| 4.1.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.1.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.1.3. Market Opportunity Analysis |
| 4.1.2. ECP Devices |
| 4.1.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.1.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.2.3. Market Opportunity Analysis |
| 4.2. Automated Technologies |
| 4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3. Market Opportunity Analysis |
| 4.3. Cell Therapy Technologies (Cell Washing and Processing) |
| 4.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.3.3. Market Opportunity Analysis |
| 4.4. Blood Bags |
| 4.4.1. Conventional Blood Bags |
| 4.4.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.4.1.3. Market Opportunity Analysis |
| 4.4.2. Inline Filter Blood Bags |
| 4.4.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.4.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.4.2.3. Market Opportunity Analysis |
| 4.5. Leukocyte Depletion Filters |
| 4.5.1. Leukocyte Depletion Platelet Filters |
| 4.5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.5.1.3. Market Opportunity Analysis |
| 4.5.2. Leukocyte Depletion RBC Filters |
| 4.5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.5.2.3. Market Opportunity Analysis |
| 4.6. Buffy Coat Pooling System |
| 4.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.6.3. Market Opportunity Analysis |
| 5. Global Transfusion Medicine Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Hospital Chains |
| 5 1 1 Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Standalone Hospitals |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Blood Banks |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Transfusion Medicine Market By End User Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Public |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Private |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Global Transfusion Medicine Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Rest of the World |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. North America Transfusion Medicine Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Apheresis Devices |
| 8.1.1.1. Plasmapheresis Devices |
| 8.1.1.2. ECP Devices |
| 8.1.2. Automated Technologies |
| 8.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
| 8.1.4. Blood Bags |
| 8.1.4.1. Conventional Blood Bags |
| 8.1.4.2. Inline Filter Blood Bags |
| 8.1.5. Leukocyte Depletion Filters |
| 8.1.5.1. Leukocyte Depletion Platelet Filters |
| 8.1.5.2. Leukocyte Depletion RBC Filters |
| 8.1.6. Buffy Coat Pooling System |
| 8.2. End User Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1. Hospital Chains |
| 8.2.2. Standalone Hospitals |
| 8.2.3. Blood Banks |
| 8.3. End User Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1. Public |
| 8.3.2. Private |
| 8.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.4.1. USA |
| 8.4.2. Canada |
| 9. Europe Transfusion Medicine Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Apheresis Devices |
| 9.1.1.1. Plasmapheresis Devices |
| 9.1.1.2. ECP Devices |
| 9.1.2. Automated Technologies |
| 9.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
| 9.1.4. Blood Bags |
| 9.1.4.1. Conventional Blood Bags |
| 9.1.4.2. Inline Filter Blood Bags |
| 9.1.5. Leukocyte Depletion Filters |
| 9.1.5.1. Leukocyte Depletion Platelet Filters |
| 9.1.5.2. Leukocyte Depletion RBC Filters |
| 9.1.6. Buffy Coat Pooling System |
| 9.2. End User Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Hospital Chains |
| 9.2.2. Standalone Hospitals |
| 9.2.3. Blood Banks |
| 9.3. End User Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Public |
| 9.3.2. Private |
| 9.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Germany |
| 9.4.2. France |
| 9.4.3. Italy |
| 9.4.4. Spain |
| 9.4.5. UK |
| 9.4.6. Rest of Europe |
| 10. Asia Pacific Transfusion Medicine Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Apheresis Devices |
| 10.1.1.1. Plasmapheresis Devices |
| 10.1.1.2. ECP Devices |
| 10.1.2. Automated Technologies |
| 10.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
| 10.1.4. Blood Bags |
| 10.1.4.1. Conventional Blood Bags |
| 10.1.4.2. Inline Filter Blood Bags |
| 10.1.5. Leukocyte Depletion Filters |
| 10.1.5.1. Leukocyte Depletion Platelet Filters |
| 10.1.5.2. Leukocyte Depletion RBC Filters |
| 10.1.6. Buffy Coat Pooling System |
| 10.2. End User Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Hospital Chains |
| 10.2.2. Standalone Hospitals |
| 10.2.3. Blood Banks |
| 10.3. End User Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Public |
| 10.3.2. Private |
| 10.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. China |
| 10.4.2. Japan |
| 10.4.3. ANZ |
| 10.4.4. India |
| 10.4.5. Rest of APAC |
| 11. Rest of the World Transfusion Medicine Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Apheresis Devices |
| 11.1.1.1. Plasmapheresis Devices |
| 11.1.1.2. ECP Devices |
| 11.1.2. Automated Technologies |
| 11.1.3. Cell Therapy Technologies (Cell Washing and Processing) |
| 11.1.4. Blood Bags |
| 11.1.4.1. Conventional Blood Bags |
| 11.1.4.2. Inline Filter Blood Bags |
| 11.1.5. Leukocyte Depletion Filters |
| 11.1.5.1. Leukocyte Depletion Platelet Filters |
| 11.1.5.2. Leukocyte Depletion RBC Filters |
| 11.1.6. Buffy Coat Pooling System |
| 11.2. End User Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Hospital Chains |
| 11.2.2. Standalone Hospitals |
| 11.2.3. Blood Banks |
| 11.3. End User Type Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Public |
| 11.3.2. Private |
| 11.4. Country Analysis, 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Brazil |
| 11.4.2. Mexico |
| 11.4.3. GCC Countries |
| 11.4.4. Rest of World |
| 12. Competition Landscape |
| 12.1. Strategic Dashboard of Top Market Players |
| 12.2. Company Profiles (Introduction, Financial Analysis, Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 12.2.1. Terumo Corporation |
| 12.2.2. Fresenius Kabi |
| 12.2.3. Haemonetics Corporation |
| 12.2.4. Asahi Kasei Medical Co., Ltd. |
| 12.2.5. Mallinckrodt Pharmaceuticals |
| 12.2.6. Macopharma |
| 12.2.7. PIT Medical Systems |
| 12.2.8. Mitra Industries Private Limited |
| 13. Research Methodology |
| 14. Key Assumptions and Acronyms |
- Medtronic
- Fresenius Kabi
- Terumo
- MEDICA S.P.A.
- Haier Biomedical
- Haemonetics
- LivaNova plc.
- Lmb Technologie GmbH
- Delcon
- Sarstedt AG &Co. KG